High Potency Compounds & Dedicated Manufacturing: A Deep-Dive into Beta Lactams
Time: 3:55 pm
day: Conference Day One
Details:
- Delving into the regulatory history of beta lactams and their requirements for dedicated facilities
- The FDA’s non-penicillin beta lactam drugs: Dissecting the cGMP framework for preventing cross-contamination
- Shedding light on the inclusion of Ezetimibe in the FDA’s draft beta lactam guidance
